AstraZeneca Neuroscience Innovative Medicines (AZ NS iMed) has partnered with clinical services and eClinical solutions provider ePharmaSolutions to optimize clinical trial management technology.
iMed will leverage IT solutions to share and manage complex data with clinical trial investigators and other external partners on a common portal.
AZ NS iMed vice president Steven Leventer said, "The capabilities brought to the table by ePharmaSolutions are aimed at enabling the AZ NS iMed to ramp up our clinical trial sites more quickly and efficiently."
Featuring an electronic trial master file (eTMF) solution and cloud technology for sharing documents securely in the portal, the ePharmaSolutions technology will be used to manage three separate neuroscience trials initially.
ePharmaSolutions founder and CEO Lance Converse said, "Our integrated trial portal, document exchange and eTMF platform will play a pivotal role in supporting the study teams as well as the investigator sites."
